Loading clinical trials...

the Evaluation of the Efficacy of TCI66207 on the Skin. | Clinical Trials | Clareo Health

COMPLETEDNA

the Evaluation of the Efficacy of TCI66207 on the Skin.

Evaluation of Skin Efficacy of TCI66207

NCT05143034•TCI Co., Ltd.

Summary

The purpose of this study is to explore the evaluation of the efficacy of TCI66207 deep-sea live-face bacteria on the skin.

Eligibility

Age

20 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Healthy volunteers aged above 20 years old
•2. Subject has dull skin.

Exclusion Criteria

•1. .Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
•2. Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
•3. Female who is pregnant or nursing or planning to become pregnant during the course of the study.
•4. Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
•5. Subjects who have large spots (area \>3 square centimeter) or abnormal acne.

Locations (1)

Research & Design Center, TCI CO., Ltd

Taipei, Neipu Township, Taiwan

Key Dates

Start Date

November 1, 2018

Primary Completion Date

November 30, 2019

Completion Date

December 31, 2019

Last Updated

December 7, 2021

Enrollment

ACTUAL participants

Conditions

Skin Diseases

Interventions

TCI66207 Essence

DIETARY_SUPPLEMENT

Placebo Essence

DIETARY_SUPPLEMENT

Deep Phenotyping of CIndU

NCT07359430

Skin DiseasesAngio-Oedema and/or Urticaria

View study

RECRUITING

Skin Reactions Related to Thoracic Implantable Chamber Dressings

NCT07158879

Skin Diseases

View study

RECRUITING

An Observational Study to Assess Objective Skin Pigmentation Variation.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 7, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

the Evaluation of the Efficacy of TCI66207 on the Skin.

Inclusion Criteria

Exclusion Criteria

Deep Phenotyping of CIndU

Skin Reactions Related to Thoracic Implantable Chamber Dressings

An Observational Study to Assess Objective Skin Pigmentation Variation.

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes

Herbal Ointment in Treating Atopic Dermatitis Topically

Trem-1 and Ultraviolet Radiation-induced Immune Suppression